Industry: Medical-Drugs Closing Price: 13.14 P/E: -8.3 Avg. Vol.: 3,948K
Company Profile: Savient Pharmaceuticals Inc. develops, manufactures, and markets human health care products for niche and wider markets. The Company offers pharmaceutical products for a wide range of medical needs such as weight gain, drugs targeting the control of elevated uric acid levels in the blood, and rheumatology.
Chart Setup: Buy Setup
Trading Strategy: We'll look to buy SVNT if it trades above 13.27 Place a protective stop under 12.50 Target 1: $14.50